Veracyte (VCYT) Tops Q2 EPS by 12c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Veracyte, Inc (VCYT) PT Raised to $55 at Needham & Company
July 30, 2021 6:28 AM EDTNeedham & Company analyst Mike Matson raised the price target on Veracyte, Inc (NASDAQ: VCYT) to $55.00 (from $54.00) while maintaining a Buy rating.
The analyst commented, "VCYT's 2Q21 revenue and EPS beat consensus. Organic revenue growth improved to 77% in 2Q21 from 5.7% in 1Q21 as... More
